Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,919 | -310 | -500 | -588 | -641 |
| Depreciation Amortization | 201 | 50 | 150 | 330 | 186 |
| Accounts receivable | -184 | N/A | N/A | N/A | N/A |
| Other Working Capital | -338 | 1,210 | -470 | -981 | 0 |
| Other Operating Activity | -1,973 | 40 | 150 | 11 | 681 |
| Operating Cash Flow | $626 | $990 | $-670 | $-1,228 | $226 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,613 | N/A | N/A | N/A | N/A |
| PPE Investments | -47 | 6 | -20 | -54 | -106 |
| Net Acquisitions | N/A | 0 | 0 | 105 | 0 |
| Sale Of Investment | 2,672 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 8 | -876 | 390 | 946 | -408 |
| Investing Cash Flow | $-980 | $-870 | $370 | $997 | $-514 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -301 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 49 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -109 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -80 | -370 | 456 | 13 |
| Financing Cash Flow | $-362 | $-80 | $-370 | $456 | $13 |
| Beginning Cash Position | 1,624 | 210 | 930 | 336 | 877 |
| End Cash Position | 909 | 250 | 260 | 560 | 336 |
| Net Cash Flow | $-715 | $40 | $-670 | $224 | $-541 |
| Free Cash Flow | |||||
| Operating Cash Flow | 626 | 990 | -670 | -1,228 | 226 |
| Capital Expenditure | -47 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 580 | 990 | -670 | -1,228 | 226 |